PAAS National® alerted pharmacies to the delay in enforcement of Electronic Prescribing for Controlled Substances (EPCS) for Medicare Part D until January 1, 2023.
The six Medicare auditing entities are responsible for auditing records, claims and payments. What is the rationale for having these auditing entities?
Being prepared for an unannounced audit is crucial and PAAS National® wants to make sure you have the tools to be successful.
PAAS would like to point out some of the updates and additions to section 11.15 of the document Billing of a Self-Administered Free COVID-19 Oral Antiviral During an Emergency.
This month, we continue with our DMEPOS mini-series by discussing yet another challenging category – immunosuppressive drugs for a transplant. Immunosuppressive drugs are only covered under Part B to maintain an organ transplant that was Medicare eligible.
Billing and dispensing OTC COVID-19 tests is widespread throughout community pharmacies.
Every 17 seconds someone is diagnosed. Noridian, Jurisdiction D, has been conducting Targeted Probe and Educate reviews of HCPCS code A5500, which is for therapeutic shoes.
Use these helpful tips and links to be prepared in case of an audit on surgical dressings.
Migraine relief medications are frequently monitored and flagged for audit due to high cost, quantities submitted, days’ supply and/or frequency of refills.
If you are a Medicare Part B supplier, then you are aware that billing Medicare B is quite different than billing other payors.
